How much revenue did OSE Immunotherapeutics generate this year?
OSE Immunotherapeutics has achieved a revenue of 42.29 M EUR this year.
OSE Immunotherapeutics Revenue 2024
OSE Immunotherapeutics Revenue
42.29 M EUR
OSE Immunotherapeutics Dividend yield
Ticker
OSE.PA
ISIN
FR0012127173
WKN
A14QXP
In 2024, OSE Immunotherapeutics's sales reached 42.29 M EUR, a 1,799.06% difference from the 2.23 M EUR sales recorded in the previous year.
The OSE Immunotherapeutics Revenue history
| YEAR | REVENUE (undefined EUR) | GROSS MARGIN (%) |
|---|---|---|
| 2026e | - | - |
| 2025e | - | - |
| 2024e | - | - |
| 2023 | - | - |
| 2022 | - | - |
| 2021 | - | - |
| 2020 | - | - |
| 2019 | - | - |
| 2018 | - | - |
| 2017 | - | - |
| 2016 | - | - |
| 2015 | - | - |
| 2014 | - | - |
| 2013 | - | - |
| 2012 | - | - |
OSE Immunotherapeutics Aktienanalyse
What does OSE Immunotherapeutics do?
Ose Immunotherapeutics SA is a French biopharmaceutical company specializing in the development of cancer and autoimmune immunotherapies. The company was founded in 2008 and is based in Nantes, France. OSE Immunotherapeutics ist eines der beliebtesten Unternehmen auf Eulerpool.com.Revenue Details
Understanding OSE Immunotherapeutics's Sales Figures
The sales figures of OSE Immunotherapeutics originate from the total revenue accrued from goods sold or services provided during a specific time period. These numbers are a direct reflection of the company’s ability to translate its products or services into revenue, indicating the demand and market presence.
Year-to-Year Comparison
Analyzing OSE Immunotherapeutics’s yearly sales data offers insights into the company’s growth and stability. An increase in sales suggests a growing demand for its offerings, efficient marketing, or expansion into new markets. Conversely, a decline might indicate market saturation, increased competition, or less effective strategies.
Impact on Investments
Investors often scrutinize OSE Immunotherapeutics's sales data to evaluate its financial health and growth prospects. Consistent sales growth can be a promising indicator of the company’s profitability and potential return on investment, influencing stock prices and investor confidence.
Interpreting Sales Fluctuations
Increases in OSE Immunotherapeutics’s sales indicate market growth, innovation, or effective marketing, often leading to a surge in stock prices. A decline, however, can signal challenges requiring strategic adjustments to enhance market share and profitability.
Frequently Asked Questions about OSE Immunotherapeutics Stock
How much was the turnover of the company OSE Immunotherapeutics compared to the previous year?
The revenue of OSE Immunotherapeutics has increased by 1,799.06% increased compared to the previous year.
What does revenue mean for investors?
The revenue of a company is an important indicator of its financial performance and attractiveness for investors.
Which factors influence the revenue of OSE Immunotherapeutics?
The revenue of OSE Immunotherapeutics is influenced by various factors, including the demand for its products and services, market conditions, and prices.
How is the revenue of OSE Immunotherapeutics measured?
Revenue is typically measured in units referring to the sale of goods and services provided by the company.
How does an increase in sales affect investments?
An increase in revenue can prompt investors to invest more money in the company as it serves as a positive signal for its financial performance and growth prospects.
What are the possible risks associated with a declining revenue?
A decline in revenue can prompt investors to invest less money in the company, as it is a negative signal for its financial performance and growth prospects.
Why is the sales revenue of OSE Immunotherapeutics so important for investors?
The revenue of OSE Immunotherapeutics is an important indicator of financial performance and attractiveness for investors.
What strategic measures can a company take to increase revenue?
A company can take various strategic measures to increase revenue, including developing new products and services, introducing new pricing models, and expanding into new markets.
How much dividend does OSE Immunotherapeutics pay?
Over the past 12 months, OSE Immunotherapeutics paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, OSE Immunotherapeutics is expected to pay a dividend of 0 EUR.
What is the dividend yield of OSE Immunotherapeutics?
The current dividend yield of OSE Immunotherapeutics is .
When does OSE Immunotherapeutics pay dividends?
OSE Immunotherapeutics pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of OSE Immunotherapeutics?
OSE Immunotherapeutics paid dividends every year for the past 0 years.
What is the dividend of OSE Immunotherapeutics?
For the upcoming 12 months, dividends amounting to 0 EUR are expected. This corresponds to a dividend yield of 0 %.
In which sector is OSE Immunotherapeutics located?
OSE Immunotherapeutics is assigned to the 'Health' sector.
Wann musste ich die Aktien von OSE Immunotherapeutics kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of OSE Immunotherapeutics from 5/3/2024 amounting to 0 EUR, you needed to have the stock in your portfolio before the ex-date on 5/3/2024.
When did OSE Immunotherapeutics pay the last dividend?
The last dividend was paid out on 5/3/2024.
What was the dividend of OSE Immunotherapeutics in the year 2023?
In the year 2023, OSE Immunotherapeutics distributed 0 EUR as dividends.
In which currency does OSE Immunotherapeutics pay out the dividend?
The dividends of OSE Immunotherapeutics are distributed in EUR.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von OSE Immunotherapeutics
Our stock analysis for OSE Immunotherapeutics Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of OSE Immunotherapeutics Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
- OSE Immunotherapeutics Revenue
- OSE Immunotherapeutics Net Income
- OSE Immunotherapeutics P/E
- OSE Immunotherapeutics P/S
- OSE Immunotherapeutics EBIT
- OSE Immunotherapeutics Dividend
- OSE Immunotherapeutics Stocks
- OSE Immunotherapeutics Market capitalization
- OSE Immunotherapeutics Debt
- OSE Immunotherapeutics Liabilities
- OSE Immunotherapeutics Equity
- OSE Immunotherapeutics AAQS
- OSE Immunotherapeutics Employees
- OSE Immunotherapeutics ROE
- OSE Immunotherapeutics ROA
- OSE Immunotherapeutics ROCE
